News

Photo
18.05.2022 • News

Petronas to Acquire Perstorp for €1.54 Billion

Malaysian petrochemicals giant Petronas Group (PCG) has conditionally agreed to acquire all of Swedish chemical producer Perstorp from Financière Forêt, a European private equity investor belonging to PAI Partners.

Photo
18.05.2022 • News

Shaheen Joins Ta’ziz and Reliance Chlor-alkali Project

Shaheen Chem Holdings Investment, a privately owned company based in the United Arab Emirates (UAE), is joining the proposed Ta’ziz and Reliance Industries joint project that will produce chlor-alkali, EDC and PVC in Ruwais, Abu Dhabi.

Photo
18.05.2022 • NewsLogistics

Successful Large-Scale SCE Projects

Large-scale projects in pharmaceutical logistics are complex, long-term and investment-intensive projects that can only be successfully implemented with an assertive and goal-oriented large-scale project organization structure.

Photo
18.05.2022 • NewsChemistry

Planning for the Unexpected

Dorothee Arns, Director General of FECC, discusses current challenges, market trends and her vision for the chemical distribution industry in Europe. The interview was conducted by Michael Reubold and Ralf Kempf.

Photo
18.05.2022 • News

GSK Officially Changes Name – to GSK

Major UK pharmaceutical producer GlaxoSmithKline is slimming down not only by spinning off its consumer health business. It is also shedding excess verbiage by trimming its name to the three-letter acronym the company is known by, GSK.

Photo
17.05.2022 • News

Avantor Plans Singapore Hub

US CDMO Avantor has announced plans to create a new manufacturing and distribution hub in Singapore in order to get closer to regional customers and strengthen its global supply chain capabilities.

Photo
17.05.2022 • News

H.I.G. Sells Valtris to SK Capital

Investment company H.I.G. Capital has agreed to sell Valtris Specialty Chemicals to an affiliate of funds managed by SK Capital Partners. Financial terms of the transaction were not disclosed. Based in Independence, Ohio, USA, the company manufactures specialty polymer additives and specialty chemicals at nine plants located around the world.

Photo
17.05.2022 • News

Sustainability to Drive Evonik’s Business Growth

After making “good progress”, both strategically and financially, in the recent past, the next phase in Evonik’s drive toward enhanced business growth will see it execute “targeted and massive investments” in green chemistry and establish sustainability as its central innovation driver, CEO Christian Kullmann said at the company’s Capital Markets Day.

Photo
16.05.2022 • News

EureKING Poised to Shake up European CDMO Scene

EureKING, a new special purpose acquisition company (SPAC) steered by former European biopharma executives, launched itself on May 9 and in a subsequent listing on the Paris-based Euronext stock exchange raised €150 million to buy up small European CDMOs that make biologics, cell and gene therapies or live biotherapeutics.

Photo
16.05.2022 • News

Wacker Opens new R&D Center in Michigan

Wacker Chemie has opened a new US regional innovation center in Ann Arbor, Michigan, dedicated to developing high-margin biotech and silicone specialties for high-tech applications. The site will also serve as headquarters of Wacker Chemical Corporation, responsible for its business in North and Central America.

Photo
16.05.2022 • NewsLogistics

Solving the Riddle of Supply Chain Visibility

Supply chain visibility (SCV) seems to be on everyone’s agenda right now. However, when talking to companies, it quickly becomes clear that everyone has a different picture of visibility. Basically, visibility is about knowing more than you knew before, and this is what most companies still agree on.

Photo
16.05.2022 • NewsLogistics

How to Make Supply Chains Resilient

When the pandemic was pounding at their doors, many industries were rattled. Healthcare and chemicals were adapting rather successfully to the new normal, as a McKinsey & Company survey reveals.

Photo
16.05.2022 • News

Pfizer Buys Biohaven for $11.6 Billion

Major drugmaker Pfizer has agreed to buy US biotech Biohaven Pharmaceutical for around $11.6 billion. Founded in 2013 and based in New Haven, Connecticut, Biohaven specializes in drugs that target neurological diseases and rare disorders.

Photo
13.05.2022 • News

FDA Restricts Use of J&J Covid Vaccine

US health authorities are restricting the use of the Johnson & Johnson Covid vaccine somewhat belatedly, citing the rare blood clotting issues that have dogged this vaccine from the start, as well as the AstraZeneca shot.

Photo
13.05.2022 • News

Novotech Boosts US Presence with NCGS Buy

Asia-Pacific contract research organization (CRO) Novotech has acquired NCGS, a US CRO with about 300 employees and a biopharma client base. Financial terms of the transaction were not disclosed. “This is a strategic move to provide US-based expertise and infrastructure for our US clients wanting trials in Asia-Pacific and the US, and for our Asia-Pacific clients wanting US clinical program, said Novotech CEO John Moller.

Photo
12.05.2022 • News

Supreme Court Unlikely to Hear Bayer’s Roundup Plea

Bayer’s advice to shareholders expressing concern about the development of the company’s stock at its early May annual general meeting, to bide their time and wait for the US Supreme Court to deal with the issue of warning labels for agrochemicals packaging, seems to have been too hasty.

Photo
12.05.2022 • News

Green Lithium and Trafigura Link for UK Refinery Project

UK lithium processing company Green Lithium has agreed terms with major commodities trader Trafigura to build a commercial lithium refinery. The facility, to be built at an undisclosed location in the UK, will supply high-purity lithium hydroxide to both UK and European markets. Wood will oversee the refinery’s engineering, construction and commissioning.

Photo
12.05.2022 • News

LyondellBasell Says It’s Quitting Russia

Olefins and polyolefins giant LyondellBasell (LYB) has become the latest multinational chemical company to announce plans to pull out of Russia partly or altogether. The Rotterdam-registered, Houston-managed company said this week it has decided “to cease operations” at two office locations in in the country. Its offices in Moscow and Togliatti have now begun winding down activities.

Photo
11.05.2022 • News

Tecnicas Reunidas Wins Ineos Cracker Project

Spain’s Tecnicas Reunidas has won a contract for Ineos’ ethylene cracker project in Antwerp, Belgium. The scope of work includes project management, engineering, procurement and construction management and supervision services. The value of the contract was not disclosed.

Photo
11.05.2022 • News

MOL Plans Large Green Hydrogen Facility

Hungarian oil, gas and petrochemicals group MOL has teamed up with US hydrogen systems supplier Plug Power to build a green hydrogen production plant in Százhalombatta. MOL is investing €22 million in the project.

Photo
11.05.2022 • News

Solvay Launches Renewables Platform

Brussels-based chemical major Solvay is launching a fourth new business platform called Renewable Materials and Biotechnology, dedicated to developing innovative and sustainable solutions for a range of markets and using renewable feedstocks and biotechnology.

Photo
10.05.2022 • News

Yara Evaluates IPO of Clean Ammonia Business

Norwegian fertilizer company Yara International is evaluating a potential initial public offering (IPO) of its Clean Ammonia business on the Oslo Stock Exchange. Yara Clean Ammonia (YCA) was established as a separate business unit in February 2021 to focus on clean ammonia and its role in zero-emission shipping fuel, power generation, green fertilizer production and other industrial applications.

11913 more News

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.